Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2.78 USD | -2.46% | -4.30% | +14.88% |
Kurzporträt
Mitarbeiterzahl: 2
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Joseph Lawler
FOU | Founder | 52 | 23.04.20 |
Chief Executive Officer | 54 | 05.10.23 | |
Daniel George
DFI | Director of Finance/CFO | 54 | 28.09.23 |
Kenneth Cundy
CTO | Chief Tech/Sci/R&D Officer | 65 | 20.05.22 |
Madison Damour
IRC | Investor Relations Contact | - | - |
Scott Anderson
IRC | Investor Relations Contact | - | 06.01.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jason Aryeh
BRD | Director/Board Member | 56 | 01.03.21 |
Kenneth Lin
BRD | Director/Board Member | 51 | 01.02.21 |
Bimal Shah
BRD | Director/Board Member | 48 | 05.10.23 |
Chief Executive Officer | 54 | 05.10.23 | |
Director/Board Member | 42 | 01.11.22 | |
Karah Parschauer
BRD | Director/Board Member | 46 | 01.02.21 |
Joseph Lawler
FOU | Founder | 52 | 23.04.20 |
Aron English
BRD | Director/Board Member | 41 | 01.06.20 |
Areta Kupchyk
BRD | Director/Board Member | 67 | 01.04.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 25 933 217 | 8 978 689 ( 34,62 %) | 0 | 34,62 % |
Unternehmenskontakt
Anebulo Pharmaceuticals, Inc.
1017 Ranch Road 620 South Suite 107
78734, Lakeway
+(512) 598-0931
http://www.anebulo.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+14.88% | 73.91 Mio. | |
-1.42% | 41.35 Mrd. | |
+42.15% | 40.38 Mrd. | |
+1.97% | 39.05 Mrd. | |
-14.19% | 26.67 Mrd. | |
+1.82% | 24.07 Mrd. | |
-24.55% | 18.36 Mrd. | |
-4.07% | 11.68 Mrd. | |
+21.36% | 11.6 Mrd. | |
+8.20% | 11.15 Mrd. |
- Börse
- Aktien
- A3CM1D Aktie
- Unternehmen Anebulo Pharmaceuticals, Inc.